Europe's securities regulator warned crypto companies on Friday not to mislead customers about the extent to which their ...

In total, 11 abstracts on givinostat were accepted for presentation at the Congress, including two for an oral presentation ...

The offer-for-sale (OFS), priced between ₹ 540 and ₹ 570 per share, marks a key milestone for the company, which has demonstrated strong revenue growth, international expansion, and improving ...

Bayer seeks European marketing authorization for investigational contrast agent, gadoquatrane: Berlin Friday, July 11, 2025, 11:00 Hrs [IST] Bayer announced the submission of a ma ...

Vertex Pharmaceuticals secured European approval for Alyftrek, reinforcing its dominance in cystic fibrosis treatment as ...

In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...

Novo Nordisk A/S (NYSE:NVO) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 23, Novo Nordisk A ...